Article ID Journal Published Year Pages File Type
1377365 Bioorganic & Medicinal Chemistry Letters 2008 5 Pages PDF
Abstract

N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure–activity relationships, and the synthesis of these inhibitors are reported herein.

Graphical abstractA novel class of selective Lck inhibitors is reported. X-ray co-crystal structural data, structure–activity relationships, and the synthesis of these inhibitors are described.Figure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , , , , , , , , , , ,